Wall Street Associates’s Oxford Immunotec Global OXFD Stock Holding History
Bought
Maintained
Sold
Other funds holding OXFD
Wall Street Associates's OXFD Position: Q4 2016 in Review
Wall Street Associates held its Oxford Immunotec Global (OXFD) position steady in Q4 2016 at 22,800 shares worth $341K. The position accounts for 0.23% of the portfolio, ranked #157.
Wall Street Associates first reported a position in OXFD in Q4 2013 and has held it in 13 quarters since. The position peaked at $4.26M in Q2 2014. 73 funds tracked by Wall St. Rank hold OXFD as of Q4 2016.
- Wall Street Associates held 22,800 shares of Oxford Immunotec Global worth $341K as of Q4 2016.
- Wall Street Associates left its Oxford Immunotec Global share count unchanged in Q4 2016.
- Oxford Immunotec Global made up 0.23% of Wall Street Associates's portfolio in Q4 2016, its #157 holding.
- Wall Street Associates first reported a position in Oxford Immunotec Global in Q4 2013 and has held it in 13 quarters since.
- Wall Street Associates's Oxford Immunotec Global position peaked at $4.26M in Q2 2014.
- 73 funds tracked by Wall St. Rank held Oxford Immunotec Global as of Q4 2016.
Based on Wall Street Associates's 13F filing for Q4 2016, filed 18 Jan 2017.